November 10, 2015


Jingle Bell Run/Walk events raise funds for more than 50 million Americans with arthritis

PARSIPPANY, NEW JERSEY [NOVEMBER 10, 2015] – Ferring Pharmaceuticals Inc. has agreed to take on a leadership role as one of three national sponsors for the more than 100 Arthritis Foundation Jingle Bell Run/Walk events taking place in cities across the country. Through this sponsorship, Ferring Pharmaceuticals will support the Arthritis Foundation’s search for a cure to the number one cause of disability in the United States, while also providing life-changing tools, resources, and science and advocacy initiatives to help arthritis sufferers in their daily lives.

“Through Ferring’s more than 25 years of research and development in the area of osteoarthritis of the knee, we have seen firsthand the impact of this common degenerative joint disease. With that said, we hope that our national sponsorship of the Arthritis Foundation will further support the people who continually struggle with arthritis,” said Aaron Graff, President & COO, Ferring Pharmaceuticals Inc.

Taking place during the end-of-year holiday season, the Jingle Bell Run/Walk for Arthritis is an important fundraising event to help conquer arthritis, which affects roughly one in five adults. More than 50 million Americans are diagnosed with arthritis, 27 million of whom suffer from osteoarthritis.

“We greatly appreciate Ferring Pharmaceuticals’ sponsorship of Jingle Bell Run/Walk and their support to fund the important scientific discoveries that create a path for new treatments and a cure,” says Meagan Fulmer, Chief Development Officer of the Arthritis Foundation. “The Arthritis Foundation is in a unique place of authority and action, with
 the purpose of finding a cure and fighting for everyday victories. We are a Champion of Yes, and so are all Jingle Bell Run/Walk participants.”

The annual holiday-themed event will host walkers and runners alike donning their most festive apparel – everything from bells on shoelaces to full holiday costumes. This 5K is sure to spread smiles, holiday cheer and a winning spirit.

Find your local event by visiting www.jbr.og. To learn more about the fight to conquer arthritis, visit

About Ferring Pharmaceuticals
Ferring Pharmaceuticals Inc. is a subsidiary of Ferring Pharmaceuticals, a privately owned, international pharmaceutical company. Ferring Pharmaceuticals specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, gastroenterology, infertility, obstetrics/gynecology, orthopaedics, and urology. For more information, call 1-888-FERRING (1-888-337-7464) or visit

About the Arthritis Foundation
The Arthritis Foundation is the Champion of Yes. Leading the fight for the arthritis community, the Foundation helps conquer everyday battles through life-changing information and resources, access to optimal care, advancements in science and community connections. The Arthritis Foundation’s goal is to chart a winning course, guiding families in developing personalized plans for living a full life – and making each day another stride towards a cure. The Foundation also publishes Arthritis Today, the award-winning magazine that reaches 4.2 million readers.

Media Contact
Colleen McCarthy

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience. ORTIKOS is a trademark of Sun Pharma Global FZE.

©2008-2020 Ferring Pharmaceuticals.  US-CORP-2000062